BIODEXA PHARMA

Updated 22 days ago
Public Limited Company
  • Active - 09216368 (CH)
  • Age: 9 years
  • ID: 51915086/7
1 Caspian Point Caspian Way Cardiff CF10 4DQ United Kingdom
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Biodexa Pharmaceuticals is a biopharmaceutical company developing a pipeline of products aimed at cancers of the brain... Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs. The Company's lead development programmes include MTX110, which is being studied in aggressive rare/orphan brain cancer indications, and tolimidone which is under development as a novel agent for the treatment of type 1 diabetes... Glioblastoma is the most common and devastating primary malignant brain tumour in adults
Also known as: Biodexa Pharma Plc, BIODEXA PHARMACEUTICALS PLC
Previous names: MIDATECH PHARMA PLC
Registration numbers: 09216368 (CH)
Primary location: Cardiff United Kingdom
Associated domains: midatechpharma.com
  • 0
  • 0
Interest Score
1
HIT Score
0.73
CEO
Stephen Stamp
CFO
Stephen Stamp
Chairman
Stephen Parker
General
in..@biodexapharma.com
InvestorRelations
ir@biodexapharma.com

UK Company Data

Company number
09216368		 Account category
GROUP		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-06-30		 Accounts last made up date
2022-12-31		 Returns next due date
2016-10-10		 Returns last made up date
2015-09-12
Num. mort. charges
4		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
4
Num. gen. partners
0		 Num. lim. partners
0
Domain
biodexapharma.com
Actual
biodexapharma.com
IP
35.214.26.191
Status
OK
Category
Company
0 comments Add a comment